Health Care & Life Sciences » Pharmaceuticals | Shanxi Zhendong Pharmaceutical Co. Ltd.

Shanxi Zhendong Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
62,004.80
34,520.50
55,165.90
193,131.10
290,478.60
150,527.50
Depreciation, Depletion & Amortization
43,951.30
78,996.50
87,478.00
125,237.10
121,344.50
151,675.20
Other Funds
32,163.50
4,953.50
224,236.10
856,313.50
42,309.10
203,002.80
Funds from Operations
118,103.30
133,581.70
206,832.00
377,866.50
510,211.60
206,743
Changes in Working Capital
217,833.30
85,961.80
54,987.50
421,380.00
460,515.90
45,983.30
Net Operating Cash Flow
99,730.00
47,619.90
151,844.50
43,513.40
49,695.70
160,759.70
Capital Expenditures
235,357.70
144,148.80
46,917.90
146,811.30
47,934.80
Sale of Fixed Assets & Businesses
15.40
-
-
-
-
Purchase/Sale of Investments
-
548.00
629,180.00
606.00
57,415.70
Net Investing Cash Flow
235,342.30
153,600.80
676,097.90
93,497.60
112,039.50
Cash Dividends Paid - Total
8,640.00
28,800.00
28,800.00
172,800.00
25,843.40
Issuance/Reduction of Debt, Net
114,650.00
11,650.00
300,827.10
218,303.30
131,152.10
Net Financing Cash Flow
138,173.50
35,496.50
496,263.20
465,210.20
147,617.80
Net Change in Cash
196,898.80
141,477.40
27,990.20
328,199.20
85,273.90
Free Cash Flow
335,087.70
96,528.90
104,926.60
190,324.70
1,760.80
Deferred Taxes & Investment Tax Credit
5,813.60
3,428.80
2,753.30
9,910.90
2,294.40
2,592.50
Net Assets from Acquisitions
-
10,000.00
-
53,919.70
6,689.00

About Shanxi Zhendong Pharmaceutical Co.

View Profile
Address
Zhendong Technology Park
Changzhi Shanxi 047100
China
Employees -
Website http://www.zdjt.com
Updated 07/08/2019
Shanxi Zhendong Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and distribution of Chinese traditional medicines and western medicines. Its main products include Yanshu injection, Norfloxacin, Shuxuening injection, Guanxinning injection, Amoxicillin Sodium for injection, Cefathiamidine for injection, and Riboflavin Sodium Phosphate for injection. The company was founded on November 22, 1993 and is headquartered in Changzhi, China.